30 November 2015 : Original article
Premature Progesterone Elevation Does Not Affect Pregnancy Outcome in High-Responder Patients Undergoing Short-Interval Coasting in IVF Cycles
Mustafa AcetAD, Lebriz Hale AktünE, Serdar BaşaranoğluCD, Betül YorgunlarF, Tuba AcetB, Aysegul DeregözüGDOI: 10.12659/MSMBR.896244
Med Sci Monit Basic Res 2015; 21:247-252
Abstract
BACKGROUND: We aimed to present the relationship between premature progesterone elevation (PPE) and clinical outcomes in high-responder patients who had a coasting period of <4 days in length due to their high risk of developing ovarian hyperstimulation syndrome (OHSS) and who were treated with a long-acting gonadotropin-releasing hormone agonist (GnRH-agonist) protocol in in vitro fertilization-embryo transfer (IVF-ET) cycles.
MATERIAL AND METHODS: This retrospective study was conducted at the University Hospital Assisted Reproductive Technology Center. The outcomes of 101 patients undergoing IVF- intracytoplasmic sperm injection (ICSI) cycles who showed a high response to COH (estradiol >4000 pg/ml and/or >20 follicles each ≥10 mm in diameter and at least 20% ≥15 mm) and who were coasted for <4 days were evaluated. Number of oocytes, 2 pronuclei (PN) embryos, implantation rate, and live birth rate were measured.
RESULTS: The incidence of PPE was 32.6%. Compared with those without PPE, patients with PPE had a higher number of oocytes retrieved. Total mature and fertilized oocytes and the mean number of embryos transferred were not significantly different between groups. Live birth rates (41.9% vs. 38.7%) and implantation rates (26.5% vs. 23%) were also not significantly divergent in the PPE and non-PPE groups, respectively.
CONCLUSIONS: P concentrations ≥1.3 ng/ml on the day of human chorionic gonadotropin (hCG) administration, designated in this study as PPE, does not appear to be related to adverse effects in terms of clinical outcomes in high-responder patients undergoing coasting <4 days due to their high risk of developing OHSS treated with a long-acting GnRH-a protocol in IVF-embryo transfer cycles.
Keywords: Chorionic Gonadotropin - administration & dosage, Embryo Transfer - methods, Estradiol - blood, Gonadotropin-Releasing Hormone - agonists, Ovarian Hyperstimulation Syndrome - prevention & control, Ovulation Induction - methods, Pregnancy, Pregnancy Outcome, Progesterone - blood, Sperm Injections, Intracytoplasmic - methods
Most Viewed Current Articles
07 Jul 2022 : Laboratory Research 4,371
Cytotoxicity, Apoptosis, Migration Inhibition, and Autophagy-Induced by Crude Ricin from Ricinus communis S...DOI :10.12659/MSMBR.936683
Med Sci Monit Basic Res 2022; 28:e936683
15 Jun 2022 : Clinical Research 4,301
Evaluation of Apical Leakage After Root Canal Obturation with Glass Ionomer, Resin, and Zinc Oxide Eugenol ...DOI :10.12659/MSMBR.936675
Med Sci Monit Basic Res 2022; 28:e936675
01 Jun 2022 : Laboratory Research 4,274
Comparison of Sealing Abilities Among Zinc Oxide Eugenol Root-Canal Filling Cement, Antibacterial Biocerami...DOI :10.12659/MSMBR.936319
Med Sci Monit Basic Res 2022; 28:e936319
30 Oct 2023 : Original article 4,159
Exploring the Impact of the COVID-19 Pandemic on Academic Burnout Among Nursing College Students in China: ...DOI :10.12659/MSMBR.940997
Med Sci Monit Basic Res 2023; 29:e940997